Document is current
Any future updates will be listed below
-
Authors
Joven, Beatriz
Manteca, Concepción Fito
Rubio, Esteban
Raya, Enrique
Pérez, Alba
Hernández, Raquel
Manrique, Sara
Núñez, Mercedes
Díaz-Cerezo, Silvia https://orcid.org/0000-0001-6351-818X
Moyano, Sebastián
Lacetera, Alessandra
García-Vicuña, Rosario
-
Funding
Funding for this research was provided by:
Eli Lilly Spain
- License Information
-
More Information
Article History
Received: 28 July 2023
Accepted: 22 September 2023
First Online: 7 October 2023
Declarations
:
: Rosario García Vicuña, Concepción Fito Manteca, Esteban Rubio, Enrique Raya, Alba Pérez, Raquel Hernández, Sara Manrique and Alessandra Lacetera declare that they have no competing interests. Beatriz Joven has received speaker honoraria from Asociación Madrileña de Neurología and has received payments to support travel to meetings from Eli Lilly and Company, and Sebastian Moyano, Silvia Díaz-Cerezo and Mercedes Núñez are full time employees at Eli Lilly and Company and minor owners of Eli Lilly and Company shares.
: The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, the Good Pharmacoepidemiology Practices (GPPs) guidelines of the International Society for Pharmacoepidemiology, and local rules and regulations. The study was sent to the Spanish Health Authorities for classification and was subsequently evaluated and approved by a central ethics committee (Comité de Etica de la Investigación con medicamentos regional de la Comunidad de Madrid), and local ethics committees as required.
